EMAIL THIS PAGE TO A FRIEND

eLife

A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity.


PMID 25738228

Abstract

Huntington's disease (HD) represents an important model for neurodegenerative disorders and proteinopathies. It is mainly caused by cytotoxicity of the mutant huntingtin protein (Htt) with an expanded polyQ stretch. While Htt is ubiquitously expressed, HD is characterized by selective neurodegeneration of the striatum. Here we report a striatal-enriched orphan G protein-coupled receptor(GPCR) Gpr52 as a stabilizer of Htt in vitro and in vivo. Gpr52 modulates Htt via cAMP-dependent but PKA independent mechanisms. Gpr52 is located within an intron of Rabgap1l, which exhibits epistatic effects on Gpr52-mediated modulation of Htt levels by inhibiting its substrate Rab39B, which co-localizes with Htt and translocates Htt to the endoplasmic reticulum. Finally, reducing Gpr52 suppresses HD phenotypes in both patient iPS-derived neurons and in vivo Drosophila HD models. Thus, our discovery reveals modulation of Htt levels by a striatal-enriched GPCR via its GPCR function, providing insights into the selective neurodegeneration and potential treatment strategies.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

32883
4-tert-Octylphenol monoethoxylate solution, 1 μg/mL in acetone, analytical standard
C16H26O2
32882
4-tert-Octylphenol monoethoxylate solution, 10 μg/mL in acetone, analytical standard
C16H26O2
B4560
6-Bnz-cAMP sodium salt, ≥98% (HPLC)
C17H15N5O7PNa
C8988
8-(4-Chlorophenylthio)-2′-O-methyladenosine 3′,5′-cyclic monophosphate monosodium hydrate, ≥98% (HPLC)
C17H16N5O6ClPSNa · xH2O
B5386
8-Bromoadenosine 3′,5′-cyclic monophosphate, ≥97% (HPLC)
C10H11BrN5O6P
B7880
8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt, ≥97% (HPLC), powder
C10H10BrN5NaO6P
A9501
Adenosine 3′,5′-cyclic monophosphate, ≥98.5% (HPLC), powder
C10H12N5O6P
A9434
Ammonium chloride, for molecular biology, suitable for cell culture, ≥99.5%
H4ClN
09718
Ammonium chloride, BioUltra, for molecular biology, ≥99.5% (AT)
H4ClN
254134
Ammonium chloride, 99.998% trace metals basis
H4ClN
326372
Ammonium chloride, 99.99% trace metals basis
H4ClN
09702
Ammonium chloride, purum p.a., ≥99.0%
H4ClN
PHR1327
Ammonium chloride, Pharmaceutical Secondary Standard; Certified Reference Material
H4ClN
09724
Ammonium chloride, tested according to Ph.Eur.
H4ClN
09683
Ammonium ion solution for ISE, 0.1 M NH4+, analytical standard (for ion-selective electrodes)
H4ClN
09685
Ammonium ion solution for ISE, 1000 mg/kg N, analytical standard (for ion-selective electrodes)
H4ClN
576794
Ammonium-14N chloride, 99.99 atom % 14N, 15N-depleted, 99% (CP)
H4Cl14N
MAB2166
Anti-Huntingtin Protein Antibody, a.a. 181-810, clone 1HU-4C8, 100 µL, Anti-Huntingtin Protein Antibody, a.a. 181-810, clone 1HU-4C8 is an antibody against Huntingtin Protein for use in ELISA, IC, IH(P), IP & WB.
MAB5360
Anti-Spinocerebellar Ataxia Type 3 Antibody, clone 1H9, 100 µL, Detect Spinocerebellar Ataxia Type 3 using this Anti-Spinocerebellar Ataxia Type 3 Antibody, clone 1H9 validated for use in ELISA, IC, IH, IP & WB.
A1300000
Ascorbic acid, European Pharmacopoeia (EP) Reference Standard
C6H8O6
1043003
Ascorbic acid, United States Pharmacopeia (USP) Reference Standard
C6H8O6
PHR1008
Ascorbic Acid
C6H8O6
B1793
Bafilomycin A1 from Streptomyces griseus, ≥90% (HPLC)
C35H58O9
14339
Bicinchoninic acid disodium salt hydrate, ≥99.0% (HPLC)
C20H10N2Na2O4 · xH2O
C6628
Chloroquine diphosphate salt, solid, ≥98%
C18H26ClN3 · 2H3PO4
10104159001
DNase I, grade II, from bovine pancreas
F6886
Forskolin, from Coleus forskohlii, ≥98% (HPLC), powder
C22H34O7
F3917
Forskolin, For use in molecular biology applications
C22H34O7
93049
Forskolin, analytical standard
C22H34O7
B1427
H-89 dihydrochloride hydrate, ≥98% (HPLC), powder
C20H20BrN3O2S · 2HCl · xH2O